Latest News
The Oxford vaccine, ChAdOx1 nCoV-19, has demonstrated strong immune responses to COVID-19 in patients, as well as a good safety profile, as the results of the Phase I/II trial are published.
In collaboration with the University of Southampton, Synairgen (both Southampton, UK) have announced positive results from their recent trial of SNG001, a novel protein based COVID-19 drug.
A research team from The Rosalind Franklin Institute, Diamond Light Source, The University of Oxford and Public Health England have engineered nanobodies from llama antibodies that show protective immune effects against SARS-CoV-2.
Journal Articles
Take a peek behind the scenes of a recent article published by Future Virology, titled ‘Pros and cons of the application…
Take a look behind the scenes of a recent Future Virology paper, titled ‘Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: Let the…
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Bacterial
How can bacterial toxins evolve to infect different tissues?
Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?
Resistance-free ‘poisoned arrow’ antibiotic kills Gram-negative bacteria
Clostridium Difficile Infection
How can bacterial toxins evolve to infect different tissues?
Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
E. Coli
Antibodies from maternal microbiota could protect newborns from infection
Multidrug efflux systems: information on evolution and mechanisms uncovered
E. coli created with world’s first synthetic and redesigned genome
H. Pylori
Organoids: a new model to study infectious diseases?
MRSA
The race for COVID-19 treatments and vaccines: February’s industry headlines
New study reveals how the household environment influences MRSA spread
Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice
Salmonella
Novel models for enteric infections – an interview with the Faherty Lab
Tuberculosis
The role of humoral immunity in TB defense – an interview with Babak Javid
Changing the administration of the BCG vaccine could improve efficacy
WHO prequalifies Ebola vaccine: November’s industry headlines
Fungal
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
The best of 2019 – an A–Z of infectious diseases research
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Aspergillosis
Fungal biofilm morphology impacts disease progression
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Novel antifungal presents opportunities for treating aspergillosis
Candidiasis
A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi
A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals
Could climate change have contributed to Candida auris emergence?
Coccidioidomycosis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Identification of membrane proteome of Paracoccidioides lutzii and its regulation by zinc
Cryptococcal Meningitis
#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week
Parasitic
Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis
Malaria: triple artemisinin-based combination therapies safe and effective
Helminthic Infections
Conference report – London Centre for Neglected Tropical Disease Research Anniversary Event
ISNTD – Female Genital Schistosomiasis: The most neglected gynaecological disease
Conference report – British Society for Parasitology Autumn Symposium
Malaria
Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis
Malaria: triple artemisinin-based combination therapies safe and effective
Neglected Tropical Diseases
Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama
Mice, introduced by maritime trade, play a key role in Toxoplasma gondii distribution
Protozoan Infections
Malaria: triple artemisinin-based combination therapies safe and effective
World Malaria Report 2019: a focus on pregnant women and children
Imaging study reveals how malaria parasites bypass antimalarial drugs
Viral
COVID-19: an update on clinical disease, immunology, masking, treatments and virology
Oxford vaccine gives strong immune response against COVID-19
Hepatitis
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Herpes
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
HR-HPV oral infection rates in England are lower than expected
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus
